Pericardial involvement in systemic sclerosis

Annals of the Rheumatic Diseases

Volumn 56, Issue 6, 1997, Pages 393-394

  Byers, R J ^a,c   Marshall, D A S ^b   Freemont, A J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b INVERCLYDE ROYAL HOSPITAL   (United Kingdom)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MAST CELL; PERICARDITIS; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

EID: 0030790756     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.56.6.393     Document Type: Article

References (15)

1. LeRoy EC. Scleroderma (systemic sclerosis). In: Kelly WN, Harris JR, Ruddy S, Sledge CB, eds. Textbook of rheumatology . Philadelphia: W B Saunders, 1981:1211-30.
2. Buckley BH, Ridolfi RL, Salyer WR, Hutchins GM. Myocardial lesions of progressive systemic sclerosis. Circulation 1976;53:483-90.
3. Botstein GR, LeRoy EC. Primary heart disease in systemic sclerosis (scleroderma): advances in clinical and pathological features, pathogenesis, and new therapeutic approaches. Am Heart J 1981;102:913-9.
4. Oram S, Stokes W. The heart in scleroderma. Br Heart J 1961;23:243-59.
5. Sackner MA, Heinz ER, Steinberg AJ. The heart in scleroderma. Am J Cardiol 1966;17:542-59.
6. D'Angelo WA, Fries JF, Masi AT, Shulman LE. Pathologic observations in systemic sclerosis (scleroderma). Am J Med 1969;46:428-40.
7. McWhorter JH, LeRoy EC. Pericardial disease in scleroderma ( systemic sclerosis). Am J Med 1974;57:566-75.
8. Lichtbroun AS, Sandhaus LM, Giorno RC, Kim H, Siebold JR. Myocardial mast cells in systemic sclerosis: a report of three fatal cases. Am J Med 1990;89:372-6.
9. Hawkins RA, Claman HN, Clark RAF, Steigerwald JC. Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis? Ann Intern Med 1985;102:182-6.
10. Qu Z, Liebler JM, Powers MR, Galey T, Ahmadi P, Huang X-N, et al. Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol 1995;147:564-73.
11. Chalkley H. Method for the quantitative morphological analysis of tissues. J Natl Cancer Inst 1943;4:47-53.
12. Smith JW, Clements PJ, Levisman J, Furst D, Ross M. Echocardiographic features of progressive systemic sclerosis (PSS): correlation with hemodynamic and post-mortem studies. Am J Med 1979;66:28-33.
13. Andrias CW. Scleroderma heart disease. Conn Med 1985;49:214-8.
14. Lee Choi K, Claman HN. Mast cells, fibroblasts, and fibrosis: new clues to the riddle of mast cells. Immunol Res 1987;6:145-52.
15. Seibold JR, Giorno RC, Claman HN. Dermal mast cell degranulation in systemic sclerosis. Arthritis Rheum 1990; 33:1702-9.